About Advanced Accelerator Applications
Advanced Accelerator Applications is a company based in Saint-genis-pouilly (France) founded in 2002 was acquired by Novartis in October 2017.. Advanced Accelerator Applications has raised $56.13 million across 2 funding rounds from investors including Novartis and HBM Partners. Advanced Accelerator Applications has completed 3 acquisitions, including Atreus Pharmaceuticals, IDB Holland and PET Net. Advanced Accelerator Applications offers products and services including Radioligand Therapies and Radionuclide Molecular Imaging. Advanced Accelerator Applications operates in a competitive market with competitors including SOFIE, Mariana Oncology, AdvanCell, Ariceum Therapeutics and Lantheus, among others.
- Headquarter Saint-genis-pouilly, France
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Advanced Accelerator Applications
-
Annual Revenue
$235.08 M (USD)48as on Dec 31, 2023
-
Net Profit
$43.24 M (USD)21as on Dec 31, 2023
-
EBITDA
$43.24 M (USD)21as on Dec 31, 2023
-
Total Equity Funding
$56.13 M (USD)
in 2 rounds
-
Latest Funding Round
$283.07 K (USD), Grant
Apr 01, 2015
-
Investors
Novartis
& 1 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Atreus Pharmaceuticals
& 2 more
-
Acquired by
Novartis
(Oct 30, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Advanced Accelerator Applications
Advanced Accelerator Applications offers a comprehensive portfolio of products and services, including Radioligand Therapies and Radionuclide Molecular Imaging. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targeted therapies using radioactive ligands to treat tumors effectively.
Imaging solutions for detecting and monitoring cancer progression.
Funding Insights of Advanced Accelerator Applications
Advanced Accelerator Applications has successfully raised a total of $56.13M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $283.07 thousand completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $283,075
-
First Round
First Round
(17 Feb 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Grant - Advanced Accelerator Applications | Valuation |
investors |
|
| Feb, 2014 | Amount | Series B - Advanced Accelerator Applications | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Advanced Accelerator Applications
Advanced Accelerator Applications has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis and HBM Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Late-stage life sciences investments are managed via VC and PE.
|
Founded Year | Domain | Location | |
|
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Advanced Accelerator Applications
Advanced Accelerator Applications has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Atreus Pharmaceuticals, IDB Holland and PET Net. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Radiopharmaceutical devices are manufactured in the Netherlands.
|
2016 | ||||
|
In vivo imaging diagnostics for autoimmune diseases are developed.
|
2007 | ||||
|
Radiopharmaceuticals are manufactured by PET Net in Germany.
|
1998 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Advanced Accelerator Applications
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Advanced Accelerator Applications Comparisons
Competitors of Advanced Accelerator Applications
Advanced Accelerator Applications operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SOFIE, Mariana Oncology, AdvanCell, Ariceum Therapeutics and Lantheus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of molecular imaging systems and radio-pharmaceuticals
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals for solid tumors are developed and pioneered.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment
|
|
| domain | founded_year | HQ Location |
Developer of drugs for systemic targeted radiation therapy to treat cancer
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic imaging agents and targeted therapeutics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Advanced Accelerator Applications
Frequently Asked Questions about Advanced Accelerator Applications
When was Advanced Accelerator Applications founded?
Advanced Accelerator Applications was founded in 2002 and raised its 1st funding round 12 years after it was founded.
Where is Advanced Accelerator Applications located?
Advanced Accelerator Applications is headquartered in Saint-genis-pouilly, France. It is registered at Saint-genis-pouilly, Ain, France.
Is Advanced Accelerator Applications a funded company?
Advanced Accelerator Applications is a funded company, having raised a total of $56.13M across 2 funding rounds to date. The company's 1st funding round was a Series B of $56.13M, raised on Feb 17, 2014.
What is the annual revenue of Advanced Accelerator Applications?
Annual revenue of Advanced Accelerator Applications is $235.08M as on Dec 31, 2023.
What does Advanced Accelerator Applications do?
Founded in 2002 as a spin-off from CERN in Geneva, Switzerland, Advanced Accelerator Applications operates in the nuclear medicine sector. Radiopharmaceuticals for PET and SPECT imaging in oncology, neurology, cardiology, and infectious diseases are developed, manufactured, and commercialized. The company, acquired by Novartis in 2017, is headquartered in Saint-Genis-Pouilly, France, with Lutathera approved by the FDA for treating certain neuroendocrine tumors.
Who are the top competitors of Advanced Accelerator Applications?
Advanced Accelerator Applications's top competitors include SOFIE, AdvanCell and Mariana Oncology.
What products or services does Advanced Accelerator Applications offer?
Advanced Accelerator Applications offers Radioligand Therapies and Radionuclide Molecular Imaging.
How many acquisitions has Advanced Accelerator Applications made?
Advanced Accelerator Applications has made 3 acquisitions, including Atreus Pharmaceuticals, IDB Holland, and PET Net.
Who are Advanced Accelerator Applications's investors?
Advanced Accelerator Applications has 2 investors. Key investors include Novartis, and HBM Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.